CLOVER HEALTH INVESTMENTS, CORP.
725 Cool Springs Blvd, Suite 320
Franklin, Tennessee 37067
January 25, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance 100 F Street, N.E.
Washington, D.C. 20549
Attn: Julia Griffith
| Re: | Clover Health Investments, Corp. |
| Registration Statement on Form S-1 |
| File No. 333-252073 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Clover Health Investments, Corp. (the “Company”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-referenced Registration Statement on Form S-1 to become effective on January 27, 2021, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter.
The Company hereby authorizes Niki Fang of Orrick, Herrington & Sutcliffe LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Niki Fang of Orrick, Herrington & Sutcliffe LLP at (415) 773-5540.
| Very truly yours,
CLOVER HEALTH INVESTMENTS, CORP. | ||
| By: | /s/ Gia Lee | |
| Name: | Gia Lee | |
| Title: | General Counsel and Corporate Secretary | |
| cc: | Vivek Garipalli, Clover Health Investments, Corp. |
| Stephen Thau, Orrick, Herrington & Sutcliffe LLP |
| William L. Hughes, Orrick, Herrington & Sutcliffe LLP |
| Niki Fang, Orrick, Herrington & Sutcliffe LLP |